Treatment Options in Early Stage (Stage I and II) of Oropharyngeal Cancer: A Narrative Review

Giuseppe Meccariello, Andrea Catalano, Giovanni Cammaroto, Giannicola Iannella, Claudio Vicini, Sheng Po Hao, Andrea De Vito*

*此作品的通信作者

研究成果: 期刊稿件文獻綜述同行評審

3 引文 斯高帕斯(Scopus)

摘要

Objective: to show an overview on the treatments’ options for stage I and II oropharyngeal carcinomasquamous cell carcinoma (OPSCC). Background: The traditional primary treatment modality of OPSCC at early stages is intensity modulated radiation therapy (IMRT). Trans-oral robotic surgery (TORS) has offered as an alternative, less invasive surgical option. Patients with human papilloma virus (HPV)-positive OPSCC have distinct staging with better overall survival in comparison with HPV-negative OPSCC patients. Methods: a comprehensive review of the English language literature was performed using PubMed, EMBASE, the Cochrane Library, and CENTRAL electronic databases. Conclusions: Many trials started examining the role of TORS in de-escalating treatment to optimize functional consequences while maintaining oncologic outcome. The head–neck surgeon has to know the current role of TORS in HPV-positive and negative OPSCC and the ongoing trials that will influence its future implementation. The feasibility of this treatment, the outcomes ensured, and the side effects are key factors to consider for each patient. The variables reported in this narrative review are pieces of a bigger puzzle called tailored, evidence-based driven medicine. Future evidence will help in the construction of robust and adaptive algorithms in order to ensure the adequate treatment for the OPSCC at early stages.

原文英語
文章編號1050
期刊Medicina (Lithuania)
58
發行號8
DOIs
出版狀態已出版 - 08 2022
對外發佈

文獻附註

Publisher Copyright:
© 2022 by the authors.

指紋

深入研究「Treatment Options in Early Stage (Stage I and II) of Oropharyngeal Cancer: A Narrative Review」主題。共同形成了獨特的指紋。

引用此